A number of physiological and psychological changes occur as we age, and many studies have shown that our gut microbiome also changes as we grow older. A fascinating new study is suggesting that a shift in gut bacteria in our middle-age could trigger a process that plays a role in cognitive decline in our later years. And diet may be the key to encouraging the growth of beneficial bacteria that benefit healthy brain aging.
The new study, led by scientists from University College Cork, set out to explore how microbiome changes in middle-age can influence brain immune cell function, and how dietary alterations can moderate those age-related changes. The researchers hypothesized that by disrupting those gut bacteria changes that may ultimately lead to cognitive decline they could prevent, or at least slow, age-related neuroinflammation and cognitive decline.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
